SL SLS SELLAS Life Sciences Group, Inc. Common Stock Loading... : Bullish and Bearish Analyst Opinions

Short SLS as the Phase 3 trial is mechanically designed to barely cross significance, control survival likely exceeds assumptions, and WT1 vaccines have a consistent record of failure in randomized trials.

Short on prepared bearish report; entry triggered by biotech strength or adverse catalyst.

u/subbanator_76_ +6: “The SLS train is leaving the station. Next stop 20$.” This is a single high-upvote comment with no counter, indicating a small following. The ticker SLS (possibly a biotech or microcap) is not widely discussed, but the conviction of a “train” suggests a momentum play among a subset of users. Not enough community consensus – treat as a low-confidence watch, not a trade. No other mentions; very speculative.

Multiple users express strong bullish sentiment on SLS, with one saying "SLS gonna make me 100k-ionaire" and another "SLS you beautiful bastard" – both upvoted +5. This indicates community conviction in a significant upward move for SLS, likely driven by some catalyst (e.g., clinical trial results or news). Go long SLS based on community enthusiasm, expecting a breakout. No specific catalyst mentioned; could be hype-driven with no fundamental support; also single ticker could be volatile.

Bearish view without an actionable short.

The author asks a clarifying question about whether the parent sold all SLS, without taking a directional position themselves.

The author mentions subscribers asking about these tickers but provides no position disclosure, forward catalyst, or explicit trade call, only joking about being trolled.

"SLS up overnight. She's coiled like a rattlesnake" (+5) suggests a breakout pattern on low volume. After-hours/moves in small caps can signal retail accumulation; "coiled" implies imminent upward move. Long SLS as a small-cap momentum play, expecting a sharp intraday rally. Low liquidity; no fundamental news; could fade quickly.

Bearish view on SLS based on the speaker’s completed analysis, anticipating imminent downside as position is prepared.

Martin Shkreli sarcastically encourages going long on SLS, implying a bearish view on the stock's prospects.

u/SlartibartfastMcGee said “Last call for SLS, still a decent entry AH tonight” with +5 upvotes, suggesting a bullish play on SELLAS Life Sciences (SLS). The “last call” phrasing implies an imminent move (e.g., catalyst like FDA news or trial results). AH entry indicates a pre‑market or after‑hours opportunity. A speculative biotech long based on community hype; likely a momentum play with binary catalyst risk. No other comments mention SLS; biotech is highly unpredictable. The user may be pumping a low‑cap stock.

Martin Shkreli expresses dislike for SLS.